The above headline sent chills up and down my spine. I always knew the Delta strain is a highly contagious killer… but to see it confirmed in black and white is my worst nightmare
I have already given you my nanoparticle level4 bio lab UlpA cartridge filter… the only nAno particle filter available to the public in the world
I recently gave you, in over a year in development, the CoronaVit state of the art supplements… But to my horror it’s now not enough.
Our vaccines are failing and at best it will be the end of the year before a new vaccine targeted to the Delta variant will be available. You need in the mean time to get a third booster shot of the existing vaccine. If and when you can.
What to do about the 1,000 times more infectious Delta mutation!!!!!!! I agonized day and night. Short of living in a clean room donning a hazmat suit I could not guarantee your safety.
Well it’s Sarah to the rescue, my youngest daughter. She just finished her exams and passed the most difficult algorithm exams I have ever seen.

So I offered a trip to Greece as a reward with her buddies… And she turned it down and wanted to come home to her Daddy… She sure knows how to tug on my heart strings.
And this is where one of those Zen moment, life changing events occurred. They would not let her on the plane… She had her Vaccination passport and had gotten a few days earlier a PCR test.
The airport would not accept any tests. The airlines know that they’ve got a huge Delta mutation spread problem. So at some airports the authorities instituted new guidelines. Before anyone could board the plane they had to get a new Covid-19 test. On the spot at a cost of 100 Euros.
Sarah called me upset because she was standing in a long line to get tested and she was afraid she would miss her flight. I told her Sarah, you are going to miss your flight anyway because it takes at least 24 hours to get the results back. She said, Dad it’s a new test, you get the results in 10 minutes and it identifies negative cases 99% of the time.
Well HELLO KITTY! I said Sarah get me a picture or the name of this test. I’ve got to have them. I am catching hell here. My millennial daughters and staff are in a rebellion. We came out of lock down and people were coming and going under a few conditions impossible to enforce. They can go off the reservation as long as they wear their masks, only hang with vaccinated individuals and avoid crowds, especially indoors…
Now what do you think the odds of that happening with the millennials who have developed the art of obfuscation and omission of pertinent information to an art form?
They are not going to give up frying on the beach… or the $5 chocolate flavored coffees and perish though no Sushi bar!
I have been dreading the coming lock down I was going to have to impose on the compound here. The variant has for a FACT defeated our vaccines and there is no booster shot targeting the Delta variant approved much less in production. And there will not be one until the end of the year. What to do?
A light went off in my head.
For the past 2 years we had demanded everyone coming on the compound wear a mask and we checked their temperature and blood oxygen levels at the gate… And this year we demanded a vaccine certificate.
So our solution could not be simpler. And it works in part because the Delta mutation is so infectious. The solution is:
At home testing… Or in my case at gate.
Give me $20 and ten minutes and I’ll give your life back.
The viral load of this Delta variant is 1,000 times more infectious than the Alpha variant… And it gets into your nose and throat in a matter of hours if you’re infected. So the solution is very simple.
Test everyone you’re about to let around you. And here is the really good part. You do not need to test everyone in the same household. Suppose your family is coming with the grand kids. If they all live in the same house all you need to do is test one person. Because the variant is so contagious they are either all infected, symptoms or not, or hopefully no one is infected… And these new test kits I have in stock well tell you in ten minutes.
I have purchased and committed to 1,000 test kits. And I can have them in your hands next week.
It’s the best home test kit on the market. I made a special purchase and can offer it to you at the lowest price anywhere. That is if you can find them in stock locally.
Announcing the:
Quidel QuickVue At-Home COVID-19 otc Test kit – Results in ten minutes

What you get:
- Two tests in each box
- Condition: New
- Brand: Quidel
- Packages/Order: 1 to 10
- Package Type: Complete Test Kit
- Order Size: Limit 10 kits x 20 tests
Introducing the QuickVue At-Home OTC COVID-19 Test available for delivery to your door – Order now and you can have it next week

Give me 10 Minutes and $20 to change your life. No more isolation… You can safely get together with family and friends…
Fast, Easy. Ready When You Are.
We have made a special purchase. In fact we bought all our supplier had. They are now out of stock until late August.
Order now supplies are limited!
I do not know how long our supplies will last. First come first served, limit 10 test kits per person.
To Order now call Jim at: 866-924-0607
Price:
One test kit containing 2 tests at $20.00 per test: $39.99 plus shipping and handling.
Ten Test kits containing 2 tests in each box, 20 in total at a cost of $19.50 per test: $389.99 plus shipping and handeling.
Special Instructions. The way we do it is we ask anyone who wants to come on the compound to isolate the best they can for 48 hours before they show up. Therefore one test is sufficient. And we can test two people per box. If they are going to stay a week or more we do a second test.
It’s great, we are back to barbecuing and having visitors once again.
More Details:
The QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home. Available direct from us at SalvaVida, everything you need is in the package and taking the test is simple.
The QuickVue At-Home OTC COVID-19 Test utilizes trusted technology used for decades by healthcare professionals and makes simple, easy-to-use COVID-19 tests easily accessible. This has been a game changer for us. Life around here is now near normal. The best it’s been in two years… Since this started.

Features/Benefits:
QUICKVUE SARS COVID19 ANTIGEN TEST
The test is authorized for home use with self-collected anterior nasal (nares) swab samples in individuals aged 2 and older. Everything you need is in the box. This test is authorized for home use and for individuals aged 2 through 14 with an adult performing the test. And for all adults.

Frequently Asked Questions
How Does the QuickVue At-Home OTC COVID-19 Test Work?
The test uses a gentle self-collected anterior nasal (nares) swab sample to determine a positive or negative COVID-19 result. The swab is swirled in a tube of reagent solution, then removed, before a test strip is inserted. After ten minutes, you can take the strip out of the tube and see your results.
Who is Quidel Corporation?
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia, Solana, Lyra, Triage and QuickVue, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world.
What is the history of the QuickVue brand?
The QuickVue brand launched in 1986 with visually read rapid diagnostics focusing on women’s health and respiratory diseases. In 1999, QuickVue Influenza A+B was the first visually read rapid test approved by the FDA for professional use. QuickVue At-Home OTC COVID-19 Test utilizes the same technology used for decades by healthcare professionals and by the QuickVue SARS Antigen Test used in professional settings, receiving emergency use authorization (EUA) by the FDA in December 2020.
What is the accuracy of the test?
In a clinical study, the QuickVue At-Home OTC COVID-19 Test identified positive cases 83.5% of the time, and identified negative cases 99.2% of the time (83.5% PPA, and 99.2% NPA, respectively), when compared to PCR.
FOR FDA EMERGENCY USE AUTHORIZATION (EUA) ONLY.
The QuickVue At-Home OTC COVID-19 Test is intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 36 hours between tests. This home test is authorized for nonprescription home use with self-collected (unobserved) direct anterior nasal (NS) swab specimens from individuals aged 14 years and older or with adult-collected anterior NS samples from individuals aged 2 years or older. This home test has not been FDA cleared or approved, but has been authorized by the FDA under an Emergency Use Authorization (EUA) for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This home test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless authorization is terminated or revoked sooner.
About Quidel and its QuickVue:
At-Home OTC COVID-19 Test
Quidel is a California-based leading diagnostic manufacturer focused on improving the quality of healthcare throughout the globe. As a trusted innovator in the medical device industry for over 40 years, Quidel launched the QuickVue brand in 1986 with visually read rapid diagnostics focusing on women’s health and respiratory diseases. In 1999, QuickVue Influenza A+B was the first visually read rapid test cleared by the FDA for professional use.